HBK Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-27,500
Closed -$4.64M 995
2020
Q4
$4.64M Sell
27,500
-9,600
-26% -$1.43M 0.03% 289
2020
Q3
$5.49M Hold
37,100
0.04% 210
2020
Q2
$6.09M Buy
+37,100
New +$5.69M 0.08% 158
2020
Q1
Sell
-53,800
Closed -$7.07M 294
2019
Q4
$7.07M Sell
53,800
-39,100
-42% -$4.53M 0.07% 181
2019
Q3
$10.4M Sell
92,900
-91,800
-50% -$10.2M 0.13% 118
2019
Q2
$20.5M Buy
184,700
+108,100
+141% +$12.7M 0.18% 45
2019
Q1
$9.94M Buy
+76,600
New +$9.31M 0.1% 174

Other funds holding LLY

HBK Investments's LLY Position: Q3 2023 in Review

HBK Investments sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 4,809 shares — an estimated $2.26M sold.

HBK Investments first reported a position in LLY in Q3 2013 and held it in 17 quarters. The position peaked at $17.2M in Q1 2018. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • HBK Investments reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 4,809 Eli Lilly shares in Q3 2023, an estimated $2.26M.
  • HBK Investments first reported a position in Eli Lilly in Q3 2013 and held it in 17 quarters.
  • HBK Investments's Eli Lilly position peaked at $17.2M in Q1 2018.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.